$CYN
Cyngn Inc. Stock $cyn

$cyn Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000121390024066682 Filed on August 08, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$47.58K	$8.665K
YoY Change	88.75%	-98.43%
Cost Of Revenue	$157.3K	$14.92K
YoY Change	270.75%	-96.77%
Gross Profit	-$109.7K	-$6.257K
YoY Change	537.45%	-107.08%
Gross Profit Margin	-230.47%	-72.21%
Selling, General & Admin	$2.603M	$2.607M
YoY Change	-2.26%	-8.4%
% of Gross Profit
Research & Development	$2.796M	$3.199M
YoY Change	-4.56%	-14.41%
% of Gross Profit
Depreciation & Amortization	$54.76K	$50.05K
YoY Change	-38.9%	-46.2%
% of Gross Profit
Operating Expenses	$2.796M	$3.199M
YoY Change	-4.56%	-14.41%
Operating Profit	-$5.508M	-$5.812M
YoY Change	-1.81%	-10.52%
Interest Expense	$46.34K	-$1.670K
YoY Change	40.8%	-108.84%
% of Operating Profit
Other Income/Expense, Net	$80.80K	-$6.748K
YoY Change	-41.53%	-104.75%
Pretax Income	-$5.427M	-$5.819M
YoY Change	-0.81%	-8.41%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$5.427M	-$5.819M
YoY Change	-0.81%	-8.41%
Net Earnings / Revenue	-11405.93%	-67154.67%
Basic Earnings Per Share	-$2.74	-$4.11
Diluted Earnings Per Share	-$2.74	-$4.11
COMMON SHARES
Basic Shares Outstanding	2.027M shares	141.5M shares
Diluted Shares Outstanding	1.982M shares	1.417M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.787M	$6.994M
YoY Change	-65.82%	-42.29%
Cash & Equivalents	$1.974M	$5.900M
Short-Term Investments	$812.8K	$1.063M
Other Short-Term Assets	$1.288M	$124.6K
YoY Change	194.9%	-89.01%
Inventory	$375.6K
Prepaid Expenses	$118.6K	$286.7K
Receivables
Other Receivables	$246.1K
Total Short-Term Assets	$4.451M	$8.333M
YoY Change	-48.2%	-37.13%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.067M	$1.961M
YoY Change	48.37%	64.65%
Goodwill
YoY Change
Intangibles	$1.488M	$986.1K
YoY Change	28.34%	77.12%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$4.030M	$3.596M
YoY Change	36.24%	56.22%
TOTAL ASSETS
Total Short-Term Assets	$4.451M	$8.333M
Total Long-Term Assets	$4.030M	$3.596M
Total Assets	$8.481M	$11.93M
YoY Change	-26.57%	-23.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$190.5K	$180.2K
YoY Change	-18.72%	-41.0%
Accrued Expenses	$457.3K	$508.2K
YoY Change	86.33%	179.61%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.832M	$2.226M
YoY Change	35.94%	37.94%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$0.00
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.832M	$2.226M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$1.832M	$2.226M
YoY Change	35.94%	37.94%
SHAREHOLDERS EQUITY
Retained Earnings	-$177.2M	-$171.8M
YoY Change	15.67%	16.31%
Common Stock	$20.00	$18.00
YoY Change	-94.32%	-94.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$1.100M
YoY Change		-87.91%
Treasury Stock Shares
Shareholders Equity	$6.649M	$9.703M
YoY Change
Total Liabilities & Shareholders Equity	$8.481M	$11.93M
YoY Change	-26.57%	-23.32%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$5.427M	-$5.819M
YoY Change	-0.81%	-8.41%
Depreciation, Depletion And Amortization	$54.76K	$50.05K
YoY Change	-38.9%	-46.2%
Cash From Operating Activities	-$5.325M	-$4.385M
YoY Change	27.07%	-9.95%
INVESTING ACTIVITIES
Capital Expenditures	$162.4K	$363.3K
YoY Change	-61.72%	967.16%
Acquisitions
YoY Change
Other Investing Activities	-$241.5K	$1.552M
YoY Change	-105.91%	-15904.28%
Cash From Investing Activities	-$403.9K	$1.189M
YoY Change	-111.04%	-2810.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.772M	6.935M
YoY Change	75.26%	563716.26%
NET CHANGE
Cash From Operating Activities	-5.325M	-4.385M
Cash From Investing Activities	-403.9K	1.189M
Cash From Financing Activities	1.772M	6.935M
Net Change In Cash	-3.957M	3.739M
YoY Change	-924.09%	-176.11%
FREE CASH FLOW
Cash From Operating Activities	-$5.325M	-$4.385M
Capital Expenditures	$162.4K	$363.3K
Free Cash Flow	-$5.487M	-$4.748M
YoY Change	18.91%	-3.16%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	cyngn	Acquisition Of Property And Equipment Included In Accounts Payable And Accrued Expenses AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses		usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-24.48
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.11
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1416758	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	489438	shares
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-12.97
	dei	Entity Registrant Name EntityRegistrantName	CYNGN INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-2007094
	dei	Security12b Title Security12bTitle	Common stock, $0.00001
	dei	Trading Symbol TradingSymbol	CYN
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40932
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1015 O’Brien Dr
	dei	Entity Address City Or Town EntityAddressCityOrTown	Menlo Park
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94025
	dei	City Area Code CityAreaCode	(650)
	dei	Local Phone Number LocalPhoneNumber	924-5905
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2026533	shares
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5930977	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3591623	usd
CY2024Q2	us-gaap	Short Term Investments ShortTermInvestments	1063131	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	4561928	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1338670	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1316426	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	8332778	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	9469977	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1961381	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1486672	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	648513	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	992292	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	986138	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1084415	usd
CY2024Q2	us-gaap	Assets Assets	11928810	usd
CY2023Q4	us-gaap	Assets Assets	13033356	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	180175	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	196963	usd
CY2024Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1354550	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1201142	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	691250	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	682718	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2225975	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2080823	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	317344	usd
CY2024Q2	us-gaap	Liabilities Liabilities	2225975	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2398167	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1769946	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1769946	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	759831	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	759831	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	18	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	8	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-171806650	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-160017619	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	9702835	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	10635189	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11928810	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13033356	usd
CY2024Q2	us-gaap	Revenues Revenues	8665	usd
CY2023Q2	us-gaap	Revenues Revenues	550952	usd
	us-gaap	Revenues Revenues	14179	usd
	us-gaap	Revenues Revenues	1423752	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	14922	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	462624	usd
	us-gaap	Cost Of Revenue CostOfRevenue	128698	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1079318	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3199078	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3737818	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6353775	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6767874	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2606869	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2845922	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5310269	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5916841	usd
CY2024Q2	us-gaap	Costs And Expenses CostsAndExpenses	5820869	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	7046364	usd
	us-gaap	Costs And Expenses CostsAndExpenses	11792742	usd
	us-gaap	Costs And Expenses CostsAndExpenses	13764033	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5812204	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6495412	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11778563	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12340281	usd
CY2024Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1669	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	18891	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-342	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	65793	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5079	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	123122	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10126	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	292331	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6748	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	142013	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10468	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	358124	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-5818952	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-6353399	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11789031	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11982157	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.11
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-12.97
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-12.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-24.48
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1416758	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	489947	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	970329	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	489438	shares
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	19420513	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1222	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	873708	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-6353399	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	13942044	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	7971191	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-597	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	615651	usd
CY2024Q2	cyngn	Issuance Of Common Stock Atthemarket Equity Financing Net Of Offering Costs IssuanceOfCommonStockAtthemarketEquityFinancingNetOfOfferingCosts	48266	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2365034	usd
CY2024Q2	cyngn	Stock Dividend Net Of Offering Costs StockDividendNetOfOfferingCosts	633493	usd
CY2024Q2	cyngn	Stock Issued During Period Value Issuance Of Common Stock For Prefunded Warrants In Connection With The Private Placement Offeri StockIssuedDuringPeriodValueIssuanceOfCommonStockForPrefundedWarrantsInConnectionWithThePrivatePlacementOfferi	-4569904	usd
CY2024Q2	cyngn	Exercise Of Prefunded Warrants In Connection With The Private Placement Offering ExerciseOfPrefundedWarrantsInConnectionWithThePrivatePlacementOffering	604	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-5818952	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	9702835	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	24117528	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	8066	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1798607	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11982157	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	13942044	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	10635189	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-597	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1269675	usd
	cyngn	Issuance Of Common Stock Atthemarket Equity Financing Net Of Offering Costs IssuanceOfCommonStockAtthemarketEquityFinancingNetOfOfferingCosts	102403	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	5017144	usd
	cyngn	Stock Dividend Net Of Offering Costs StockDividendNetOfOfferingCosts	633493	usd
	cyngn	Stock Issued During Period Value Issuance Of Common Stock For Prefunded Warrants In Connection With The Private Placement Offeri StockIssuedDuringPeriodValueIssuanceOfCommonStockForPrefundedWarrantsInConnectionWithThePrivatePlacementOfferi	-4569903	usd
	cyngn	Exercise Of Prefunded Warrants In Connection With The Private Placement Offering ExerciseOfPrefundedWarrantsInConnectionWithThePrivatePlacementOffering	552	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11789031	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	9702835	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11789031	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11982157	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	455879	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	474990	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1269675	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1798607	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	88912	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	291555	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-118831	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	19729	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	473047	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-16788	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	149460	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-155403	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	76756	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10225478	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10246946	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	577497	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	481777	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	32381	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	101991	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	7022292	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	17011782	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	10610000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	20304000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2977830	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2708450	usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	5017144	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4570455	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	597	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8066	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9587002	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8066	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2339354	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-7530430	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3591623	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10586273	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5930977	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3055843	usd
	cyngn	Acquisition Of Property And Equipment Included In Accounts Payable And Accrued Expenses AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses	132405	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11800000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12000000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-171800000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-160000000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10200000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10200000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5900000	usd
CY2024Q2	us-gaap	Short Term Investments ShortTermInvestments	1100000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3600000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	4600000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the balance sheet date, as well as reported amounts of revenue and expenses during the reporting period. The Company’s significant estimates and judgments include but are not limited to internal-use software and developed software to be sold, leased or marketed, warrants and share-based compensation. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, which is placed with high-credit-quality financial institutions and at times exceeds federally insured limits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash maintained with domestic financial institutions generally exceed the Federal Deposit Insurance Corporation insurable limit. To date, the Company has not experienced any losses on its deposits of cash. Cyngn invests in U.S. Treasury securities and carries these at amortized cost and recognizes gains and losses when realized.</p>
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5900000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3600000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P15Y
CY2022Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	100000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P15Y
CY2024Q2	us-gaap	Advertising Expense AdvertisingExpense	39900	usd
CY2023Q2	us-gaap	Advertising Expense AdvertisingExpense	15303	usd
	us-gaap	Advertising Expense AdvertisingExpense	130999	usd
	us-gaap	Advertising Expense AdvertisingExpense	39117	usd
	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	0	usd
	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	300	usd
	us-gaap	Accounts Receivable Sale AccountsReceivableSale	1977	usd
CY2024Q2	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	109493	usd
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	0	usd
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	1100000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	4600000	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	286696	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	385474	usd
CY2024Q2	us-gaap	Security Deposit SecurityDeposit	163723	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	155729	usd
CY2024Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	763624	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	765697	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	124627	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	9526	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1338670	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1316426	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2896991	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2322009	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	935610	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	835337	usd
CY2024Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	1961381	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	1486672	usd
CY2024Q2	us-gaap	Depreciation Depreciation	50052	usd
CY2023Q2	us-gaap	Depreciation Depreciation	93039	usd
	us-gaap	Depreciation Depreciation	96886	usd
	us-gaap	Depreciation Depreciation	174502	usd
CY2024Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	42500	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	41250	usd
CY2024Q2	cyngn	Credit Card Payable CreditCardPayable	139853	usd
CY2023Q4	cyngn	Credit Card Payable CreditCardPayable	1103	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	508162	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	214286	usd
CY2024Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	706535	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	985753	usd
CY2024Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1354550	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1201142	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	81000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	384632	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	320526	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	705158	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	13908	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	691250	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y11M1D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y5M1D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0391	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0305	pure
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	178354	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	149261	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	359965	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	291847	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	172631	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	144177	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	343779	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	282199	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5914	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9742	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11827	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	18289	usd
CY2024Q2	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	66107	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-118831	usd
CY2024Q2	us-gaap	Salvage And Subrogation Recoveries Value SalvageAndSubrogationRecoveriesValue	0	usd
CY2023Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	50000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	30000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	11827	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	23654	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	23654	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	23654	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	23654	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	879695	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	986138	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1769946	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1769946	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	759831	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	759831	shares
CY2024Q2	cyngn	Issuance Of Common Stock Upon Exercise Of Prefunded Warrantsin Shares IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares	302000	shares
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.00001
CY2024Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.09999
	cyngn	Transaction Expenses Payable TransactionExpensesPayable	5200000	usd
CY2023Q4	cyngn	Issuance Of Common Stock Upon Exercise Of Prefunded Warrantsin Shares IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares	218666	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.00001
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.15
CY2023Q4	cyngn	Transaction Expenses Payable TransactionExpensesPayable	5000000	usd
CY2023Q4	cyngn	Other Direct Costs OtherDirectCosts	500000	usd
CY2023Q2	cyngn	Commission Proceed Percentage CommissionProceedPercentage	0.03	pure
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	6825672	usd
	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	139299	usd
	us-gaap	Other Labor Related Expenses OtherLaborRelatedExpenses	60465	usd
CY2023Q4	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.10	pure
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-5818952	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-6353399	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	1416758	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	489947	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.11
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-12.97
	us-gaap	Net Income Loss NetIncomeLoss	-11789031	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11982157	usd
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	970329	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	489438	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-12.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-24.48
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms	The resulting fair value is recognized on a straight-line basis over the period during which an employee is required to provide service in exchange for the award. The Company has elected to recognize forfeitures as they occur. Stock options generally vest over four years and have a contractual term of ten years.
CY2023Q4	cyngn	Common Stock Outstanding Percentage CommonStockOutstandingPercentage	0.15	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	87038000000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	6565	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	171204	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	102.03
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y1M9D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	115439	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	710	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.43
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	4484	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	158.38
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	167430	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	100.13
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M29D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	167430	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	100.13
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y9M29D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	99374	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	96.13
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y8M1D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	175063	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	104.27
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M13D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	42530	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3166	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	17.85
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	10799	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	143.03
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	167430	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	100.13
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M29D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	167430	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	100.13
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y9M29D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	99374	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	96.13
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y8M1D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1764	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	278.33
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	2160	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.18
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1314	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	184.6
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2610	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	104.42
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	9.8
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	55.55
CY2024Q2	us-gaap	Share Price SharePrice	17.85
CY2023Q2	us-gaap	Share Price SharePrice	103.26
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y7D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y7D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0417	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0361	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5319	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5272	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	615651	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	873707	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1269675	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1798607	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	4900000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y4M24D
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-12.15
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-12.97
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	489947	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	970329	shares
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	cyngn	Cash Paid During The Year For Income Taxes CashPaidDuringTheYearForIncomeTaxes		usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2024Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet		usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet		usd
CY2023Q4	us-gaap	Salvage And Subrogation Recoveries Value SalvageAndSubrogationRecoveriesValue		usd
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1416758	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	489947	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.11
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	489438	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	970329	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-12.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-24.48
CY2024Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2024Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001874097

Files In Submission

Name	View Source	Status
0001213900-24-066682-index-headers.html	Edgar Link	pending
0001213900-24-066682-index.html	Edgar Link	pending
0001213900-24-066682.txt	Edgar Link	pending
0001213900-24-066682-xbrl.zip	Edgar Link	pending
cyngn-20240630.xsd	Edgar Link	pending
ea0209932-10q_cyngn.htm	Edgar Link	pending
ea020993201ex31-1_cyngn.htm	Edgar Link	pending
ea020993201ex31-2_cyngn.htm	Edgar Link	pending
ea020993201ex32-1_cyngn.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
cyngn-20240630_def.xml	Edgar Link	unprocessable
cyngn-20240630_lab.xml	Edgar Link	unprocessable
cyngn-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0209932-10q_cyngn_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cyngn-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CYN
Cyngn Inc. Stock $cyn

2024 Q3 Form 10-Q Financial Statement

#000121390024066682 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYN Cyngn Inc. Stock $cyn

2024 Q3 Form 10-Q Financial Statement

#000121390024066682 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYN
Cyngn Inc. Stock $cyn